◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › SIGA

SIGA Technologies, Inc. (SIGA) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-07-10

SIGA Technologies, Inc. (SIGA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in New York, United States with about 49 employees. Its market capitalization is roughly $251 million. In the fiscal year ended 2025-12-31, SIGA reported $95M in revenue and $23M in net income.

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc.

Interactive charts & full statements → Open the SIGA valuation workbench →

SIGA Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$95M$139M$140M$111M
Gross Profit$65M$107M$122M$100M
Operating Income (EBIT)$24M$70M$84M$43M
Net Income$23M$59M$68M$34M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SIGA Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-31
Total Revenue$6M$4M$3M$81M$7M
Gross Profit$3M$1M$2M$56M$7M
Operating Income (EBIT)($5M)($10M)($10M)$46M($2M)
Net Income($4M)($5M)($6M)$36M($0M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SIGA Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid($43M)($43M)($32M)($33M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SIGA Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Dividends Paid($0M)($0M)($0M)($43M)$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SIGA Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$220M$244M$254M$195M
Total Liabilities$21M$28M$58M$25M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SIGA viewer.

Other Companies in Drug Manufacturers - Specialty & Generic

← SIGAll stocksSIGI →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.